Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Tonix Pharmaceuticals Holding Corporation TNXP

Healthcare Biotechnology
Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product... see more

Current News (NDAQ:TNXP)

Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026

GlobeNewswire 6 days ago

Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering

GlobeNewswire December 29, 2025

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

GlobeNewswire December 29, 2025

Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University

GlobeNewswire December 16, 2025

Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

GlobeNewswire December 9, 2025

Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder

GlobeNewswire November 24, 2025

Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA(TM) (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment

GlobeNewswire November 17, 2025

Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire November 10, 2025

Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference

GlobeNewswire November 6, 2025
View More News ››

Opinion & Analysis (NDAQ:TNXP)

Eight ways to leverage the small-cap biotech bull market: Ajay Tandon and Jay Albany of SeeThruEquity

Gail Dutton October 30, 2015
View More Opinion ››

Bullboard Posts (NDAQ:TNXP)

Still staying with this stock.

It is starting to climb upwards again and it's looking really good here shareholders today 
coolfooldumbguy - May 16, 2025

Pump??

Looks like we’re heading to fill that January gap. Question is — are we gonna close it completely or take a dive from there?
Ethan198223 - March 21, 2025

RE:RE:What has gone on with this one ?

The last one posted before I finished proof reading - here it is again without the spelling mistakes. I see the high price in January...
ghayes - February 28, 2025

RE:What has gone on with this one ?

Ok -  I wee the high price in January must have been something to do with the reversse split.   My quewstion now is...
ghayes - February 28, 2025

What has gone on with this one ?

I see that December 24 through January 25  TNXP was $40 to $50.   Now its $8 ,   What happened?  Will it...
ghayes - February 27, 2025

Buy buddy buy because it's taking off this morning.

And furthermore you guys will be left behind.
coolfooldumbguy - February 7, 2025
View more Bullboard ››

North Peak Resources Ltd.

North Peak Resources Ltd.

North Peak Resources Ltd. operates as a gold exploration and development company. The company’s flagship project is the ...
View More »

Podcasts